Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study

Conclusions
Daily esomeprazole 20 mg is efficacious and well tolerated in reducing the recurrence of peptic ulcer in East-Asian patients with a history of ulcers who are taking low-dose ASA for cardiovascular protection.

ClinicalTrial.gov identifier
NCT01069939.

Source: Gut - June 6, 2014 Category: Gastroenterology Authors: Sugano, K., Choi, M.-G., Lin, J.-T., Goto, S., Okada, Y., Kinoshita, Y., Miwa, H., Chiang, C.-E., Chiba, T., Hori, M., Fukushima, Y., Kim, H.-S., Chang, C.-Y., Date, M., on behalf of the LAVENDER Study Group Tags: Ulcer Stomach Source Type: research